Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-11-19

Clinical Trial Update: Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating low-dose dexamethasone for newly diagnosed pulmonary sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexamethasone (Decadron) (dexamethasone)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Sarcoidosis | Phase 3 | Status: UNKNOWN